During the past decade, Diagnamics Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 17 clinical trials were completed, i.e. on average, 85% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diagnamics Inc." #1 sponsor was "Allergan" with 5 trials, followed by "Bayer" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diagnamics Inc." #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "DuPont Nutrition and Health" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Neothetics, Inc" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Diagnamics Inc." are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Cardiovascular Disease" (2 trials), "Central Abdominal Bulging" (2 trials) and "Chronic Idiopathic Constipation" (2 trials). Many other conditions were trialed in "Diagnamics Inc." in a lesser frequency.

Most popular intervention types in "Diagnamics Inc." are "Drug" (22 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Relamorelin" (3 trials), "LIPO-202" (2 trials), "Linaclotide" (2 trials) and "Vilaprisan (BAY1002670)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Diagnamics Inc." are 22 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Diagnamics Inc.". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Diagnamics Inc., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Diagnamics Inc., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".